XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (14565)	9/15/2000 1:22:13 PM
From: Bluegreen	Read Replies (1) of 17367

George, NOBODY knows the answer to that. I would guess at once again too small of a sample size. What Manfred and Cacaito leave out is the fact that only one or two more deaths in the placebo group would of swung it over into statistical significance. BUT that cuts both ways also.......with a trial this small numbers could of been much worse for Xoma the way this trial was designed. Why would anyone test Neuprex under these circumstances???? Remember the FDA was involved in the design of this trial and of course you ask yourself......why did Xoma go along with it???? One could see from the Baboon study the power and importance of giving Neuprex immediately along with antibiotics.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next